Toxicity and bone marrow response of patients with hairy cell leukemia treated with biosynthetic (recombinant) alpha-2-interferon

Blut. 1985 Jan;50(1):33-4. doi: 10.1007/BF00319768.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Bone Marrow Examination
  • Female
  • Hemoglobins
  • Humans
  • Interferon Type I / therapeutic use*
  • Leukemia, Hairy Cell / drug therapy*
  • Leukocyte Count
  • Male
  • Middle Aged
  • Platelet Count
  • Time Factors

Substances

  • Hemoglobins
  • Interferon Type I